Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Stamp
High Efficacy and Low Toxicity of Weekly Docetaxel Given as First-Line Treatment for Metastatic Breast Cancer
Oncology
Medicine
Cancer Research
Oncology
Related publications
Weekly Docetaxel in the Treatment of Metastatic Breast Cancer
Therapeutics and Clinical Risk Management
Capecitabine in Combination With Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: An Observational Study
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Outcome of Eribulin as a Late Treatment Line for Thai Metastatic Breast Cancer Patients
OncoTargets and Therapy
Oncology
Pharmacology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients
Cancers
Cancer Research
Oncology
First-Line Treatment of Metastatic Lung Cancer—New Developments
Oncology & Hematology Review (US)
Multicenter Phase II Study With Weekly Bendamustine and Paclitaxel as First- Or Later-Line Therapy in Patients With Metastatic Breast Cancer: RiTa II Trial
Breast Care
Surgery
Oncology
Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progression as First-Line Chemotherapy in Patients With HER2+ Metastatic Breast Cancer: HERTAX Trial
Clinical Breast Cancer
Cancer Research
Oncology
